{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:32:46Z","timestamp":1783999966213,"version":"3.55.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1038\/ncpneph0378","type":"journal-article","created":{"date-parts":[[2006,12,20]],"date-time":"2006-12-20T15:35:22Z","timestamp":1166628922000},"page":"20-30","source":"Crossref","is-referenced-by-count":98,"title":["Anemia in diabetes: marker or mediator of microvascular disease?"],"prefix":"10.1038","volume":"3","author":[{"given":"Merlin C","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneph0378_CR1","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1185\/030079904X2763","volume":"20","author":"W McClellan","year":"2004","unstructured":"McClellan W et al. (2004) The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin 20: 1501\u20131510","journal-title":"Curr Med Res Opin"},{"key":"BFncpneph0378_CR2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.2337\/diacare.26.4.1164","volume":"26","author":"MC Thomas","year":"2003","unstructured":"Thomas MC et al. (2003) Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care 26: 1164\u20131169","journal-title":"Diabetes Care"},{"key":"BFncpneph0378_CR3","first-page":"22","volume":"9","author":"AP Lundin","year":"1989","unstructured":"Lundin AP (1989) Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy. Semin Nephrol 9: 22\u201329","journal-title":"Semin Nephrol"},{"key":"BFncpneph0378_CR4","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1990) Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group. BMJ 300: 573\u2013578","DOI":"10.1136\/bmj.300.6724.573"},{"key":"BFncpneph0378_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/CS20050184","volume":"110","author":"PM Srivastava","year":"2005","unstructured":"Srivastava PM et al. (2005) Diastolic dysfunction is associated with anaemia in patients with type II diabetes. Clin Sci (Lond) 110: 109\u2013116","journal-title":"Clin Sci (Lond)"},{"key":"BFncpneph0378_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.ajkd.2005.09.007","volume":"47","author":"N Volkova","year":"2006","unstructured":"Volkova N and Arab L (2006) Evidence-based systematic literature review of hemoglobin\/hematocrit and all-cause mortality in dialysis patients. Am J Kidney Dis 47: 24\u201336","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archinte.162.12.1401","volume":"162","author":"BC Astor","year":"2002","unstructured":"Astor BC et al. (2002) Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988\u20131994). Arch Intern Med 162: 1401\u20131408","journal-title":"Arch Intern Med"},{"key":"BFncpneph0378_CR8","unstructured":"[No authors listed] 2005 KEEP 2004 Data Report. Am J Kidney Dis 45 (Suppl 2): S8\u2013S13, S76\u2013S77"},{"key":"BFncpneph0378_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5414\/CNP66011","volume":"66","author":"D Lorber","year":"2006","unstructured":"Lorber D and Reddan D (2006) Clinical characteristics of chronic kidney disease patients with and without diabetes: a subanalysis of the PAERI study. Clin Nephrol 66: 11\u201316","journal-title":"Clin Nephrol"},{"key":"BFncpneph0378_CR10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5694\/j.1326-5377.2006.tb00499.x","volume":"185","author":"MC Thomas","year":"2006","unstructured":"Thomas MC et al. (2006) The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust 185: 140\u2013144","journal-title":"Med J Aust"},{"key":"BFncpneph0378_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2337\/diacare.24.3.495","volume":"24","author":"DR Bosman","year":"2001","unstructured":"Bosman DR et al. (2001) Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 24: 495\u2013499","journal-title":"Diabetes Care"},{"key":"BFncpneph0378_CR12","first-page":"83","volume":"11","author":"E Ishimura","year":"1998","unstructured":"Ishimura E et al. (1998) Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 11: 83\u201386","journal-title":"J Nephrol"},{"issue":"Suppl 4","key":"BFncpneph0378_CR13","first-page":"S52","volume":"42","author":"AJ Collins","year":"2003","unstructured":"Collins AJ (2003) Annual data report: National Kidney Foundation Kidney Early Evaluation Program (KEEP) Am J Kidney Dis 42 (Suppl 4): S52\u2013S55","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1053\/j.ajkd.2006.06.011","volume":"48","author":"M Thomas","year":"2006","unstructured":"Thomas M et al. (2006) The epidemiology of hemoglobin levels in patients with type 2 diabetes. Am J Kidney Dis 48: 537\u2013545","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR15","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/ndt\/gfh248","volume":"19","author":"MC Thomas","year":"2004","unstructured":"Thomas MC et al. (2004) The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit. Nephrol Dial Transplant 19: 1792\u20131797","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0378_CR16","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1210\/jc.2004-0678","volume":"89","author":"MC Thomas","year":"2004","unstructured":"Thomas MC et al. (2004) Anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 89: 4359\u20134363","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0378_CR17","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2337\/diacare.28.5.1118","volume":"28","author":"KJ Craig","year":"2005","unstructured":"Craig KJ et al. (2005) Anemia and diabetes in the absence of nephropathy. Diabetes Care 28: 1118\u20131123","journal-title":"Diabetes Care"},{"key":"BFncpneph0378_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.diabres.2005.04.003","volume":"70","author":"T Saito","year":"2005","unstructured":"Saito T et al. (2005) Normocytic normochromic anemia due to automatic neuropathy in type 2 diabetic patients without severe nephropathy: a possible role of microangiopathy. Diabetes Res Clin Pract 70: 239\u2013247","journal-title":"Diabetes Res Clin Pract"},{"key":"BFncpneph0378_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000189580","volume":"75","author":"S Inomata","year":"1997","unstructured":"Inomata S et al. (1997) Serum levels of erythropoietin as a novel marker reflecting the severity of diabetic nephropathy. Nephron 75: 426\u2013430","journal-title":"Nephron"},{"key":"BFncpneph0378_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2174\/1573399052952587","volume":"1","author":"MC Thomas","year":"2005","unstructured":"Thomas MC et al. (2005) Anemia in diabetes: an emerging complication of microvascular disease. Current Diabet Rev 1: 107\u2013126","journal-title":"Current Diabet Rev"},{"key":"BFncpneph0378_CR21","first-page":"F942","volume":"256","author":"KU Eckardt","year":"1989","unstructured":"Eckardt KU et al. (1989) Regulation of erythropoietin production is related to proximal tubular function. Am J Physiol 256: F942\u2013F947","journal-title":"Am J Physiol"},{"key":"BFncpneph0378_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archinte.165.4.466","volume":"165","author":"MC Thomas","year":"2005","unstructured":"Thomas MC et al. (2005) Anemia with impaired erythropoietin response in diabetic patients. Arch Intern Med 165: 466\u2013469","journal-title":"Arch Intern Med"},{"key":"BFncpneph0378_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1046\/j.1464-5491.2002.00634.x","volume":"19","author":"DR Bosman","year":"2002","unstructured":"Bosman DR et al. (2002) Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med 19: 65\u201369","journal-title":"Diabet Med"},{"key":"BFncpneph0378_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1046\/j.1523-1755.1998.00809.x","volume":"53","author":"PL Brito","year":"1998","unstructured":"Brito PL et al. (1998) Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 53: 754\u2013761","journal-title":"Kidney Int"},{"key":"BFncpneph0378_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.ackd.2005.01.008","volume":"12","author":"MC Thomas","year":"2005","unstructured":"Thomas MC et al. (2005) Tubular changes in early diabetic nephropathy. Adv Chronic Kidney Dis 12: 177\u2013186","journal-title":"Adv Chronic Kidney Dis"},{"key":"BFncpneph0378_CR26","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/01.ASN.0000128047.13396.48","volume":"15","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M et al. (2004) Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 15: 1574\u20131581","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph0378_CR27","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.2337\/diabetes.53.12.3226","volume":"53","author":"SB Catrina","year":"2004","unstructured":"Catrina SB et al. (2004) Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 53: 3226\u20133232","journal-title":"Diabetes"},{"key":"BFncpneph0378_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.0001-6772.2003.01206.x","volume":"179","author":"AP Zou","year":"2003","unstructured":"Zou AP and Cowley AW Jr (2003) Reactive oxygen species and molecular regulation of renal oxygenation. Acta Physiol Scand 179: 233\u2013241","journal-title":"Acta Physiol Scand"},{"key":"BFncpneph0378_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4419-8997-0_6","volume":"543","author":"S Donnelly","year":"2003","unstructured":"Donnelly S (2003) Why is erythropoietin made in the kidney? The kidney functions as a critmeter. Adv Exp Med Biol 543: 73\u201387","journal-title":"Adv Exp Med Biol"},{"key":"BFncpneph0378_CR30","first-page":"103","volume":"76","author":"PH Finne","year":"1970","unstructured":"Finne PH and Skoglund RW (1970) Erythropoietin production in the rat following splanchnic neurectomy. J Lab Clin Med 76: 103\u2013106","journal-title":"J Lab Clin Med"},{"key":"BFncpneph0378_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1046\/j.1464-5491.1999.00172.x","volume":"16","author":"AS Winkler","year":"1999","unstructured":"Winkler AS et al. (1999) Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med 16: 813\u2013819","journal-title":"Diabet Med"},{"key":"BFncpneph0378_CR32","first-page":"241","volume":"44","author":"RF Jeffrey","year":"1995","unstructured":"Jeffrey RF et al. (1995) Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation. Clin Nephrol 44: 241\u2013247","journal-title":"Clin Nephrol"},{"key":"BFncpneph0378_CR33","first-page":"407","volume":"3","author":"PE Jennings","year":"1986","unstructured":"Jennings PE et al. (1986) Sodium transport across erythrocyte membranes in diabetes mellitus. Diabetes Res 3: 407\u2013410","journal-title":"Diabetes Res"},{"key":"BFncpneph0378_CR34","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1210\/jcem-67-6-1129","volume":"67","author":"I Testa","year":"1988","unstructured":"Testa I et al. (1988) Abnormal membrane fluidity and acetylcholinesterase activity in erythrocytes from insulin-dependent diabetic patients. J Clin Endocrinol Metab 67: 1129\u20131133","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0378_CR35","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2337\/diab.38.7.825","volume":"38","author":"P Baldini","year":"1989","unstructured":"Baldini P et al. (1989) Membrane lipid alterations and Na+-pumping activity in erythrocytes from IDDM and NIDDM subjects. Diabetes 38: 825\u2013831","journal-title":"Diabetes"},{"key":"BFncpneph0378_CR36","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1073\/pnas.86.9.3327","volume":"86","author":"R Kowluru","year":"1989","unstructured":"Kowluru R et al. (1989) Reversible sodium pump defect and swelling in the diabetic rat erythrocyte: effects on filterability and implications for microangiopathy. Proc Natl Acad Sci USA 86: 3327\u20133331","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneph0378_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1084\/jem.166.2.539","volume":"166","author":"H Vlassara","year":"1987","unstructured":"Vlassara H et al. (1987) Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages: a model for turnover of aging cells. J Exp Med 166: 539\u2013549","journal-title":"J Exp Med"},{"key":"BFncpneph0378_CR38","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0026-0495(99)90189-0","volume":"48","author":"SK Jain","year":"1999","unstructured":"Jain SK et al. (1999) Effect of vitamin E and N-acetylcysteine on phosphatidylserine externalization and induction of coagulation by high-glucose-treated human erythrocytes. Metabolism 48: 957\u2013959","journal-title":"Metabolism"},{"key":"BFncpneph0378_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/cbf.1129","volume":"23","author":"H Resmi","year":"2005","unstructured":"Resmi H et al. (2005) In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes. Cell Biochem Funct 23: 163\u2013168","journal-title":"Cell Biochem Funct"},{"key":"BFncpneph0378_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.7326\/0003-4819-86-4-425","volume":"86","author":"CM Peterson","year":"1977","unstructured":"Peterson CM et al. (1977) Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med 86: 425\u2013429","journal-title":"Ann Intern Med"},{"key":"BFncpneph0378_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3109\/00365519009091583","volume":"50","author":"A Schmitz","year":"1990","unstructured":"Schmitz A (1990) Increased urinary haemoglobin in diabetics with microalbuminuria\u2014measured by an ELISA. Scand J Clin Lab Invest 50: 303\u2013308","journal-title":"Scand J Clin Lab Invest"},{"key":"BFncpneph0378_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1067\/mlc.2002.126504","volume":"140","author":"AB Manodori","year":"2002","unstructured":"Manodori AB and Kuypers FA (2002) Altered red cell turnover in diabetic mice. J Lab Clin Med 140: 161\u2013165","journal-title":"J Lab Clin Med"},{"key":"BFncpneph0378_CR43","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2337\/diacare.23.9.1384","volume":"23","author":"CE De Block","year":"2000","unstructured":"De Block CE et al. (2000) Soluble transferrin receptor level: a new marker of iron deficiency anemia, a common manifestation of gastric autoimmunity in type 1 diabetes. Diabetes Care 23: 1384\u20131388","journal-title":"Diabetes Care"},{"key":"BFncpneph0378_CR44","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/01.mop.0000142347.74135.73","volume":"16","author":"WR Treem","year":"2004","unstructured":"Treem WR (2004) Emerging concepts in celiac disease. Curr Opin Pediatr 16: 552\u2013559","journal-title":"Curr Opin Pediatr"},{"key":"BFncpneph0378_CR45","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1464-5491.2004.01196.x","volume":"21","author":"MC Thomas","year":"2004","unstructured":"Thomas MC et al. (2004) Elevated iron indices in patients with diabetes. Diabet Med 21: 798\u2013802","journal-title":"Diabet Med"},{"key":"BFncpneph0378_CR46","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.2337\/diabetes.51.8.2348","volume":"51","author":"JM Fernandez-Real","year":"2002","unstructured":"Fernandez-Real JM et al. (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51: 2348\u20132354","journal-title":"Diabetes"},{"key":"BFncpneph0378_CR47","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1523-1755.2004.00868.x","volume":"66","author":"MC Thomas","year":"2004","unstructured":"Thomas MC et al. (2004) Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes. Kidney Int 66: 1167\u20131172","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"BFncpneph0378_CR48","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1093\/ndt\/17.suppl_1.67","volume":"17","author":"R Dikow","year":"2002","unstructured":"Dikow R et al. (2002) How should we manage anaemia in patients with diabetes? Nephrol Dial Transplant 17 (Suppl 1): S67\u2013S72","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0378_CR49","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.2337\/diacare.26.5.1530","volume":"26","author":"H Ueda","year":"2003","unstructured":"Ueda H et al. (2003) Factors affecting progression of renal failure in patients with type 2 diabetes. Diabetes Care 26: 1530\u20131534","journal-title":"Diabetes Care"},{"key":"BFncpneph0378_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s001250050694","volume":"40","author":"H Yokoyama","year":"1997","unstructured":"Yokoyama H et al. (1997) Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia 40: 405\u2013411","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"BFncpneph0378_CR51","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1053\/ajkd.2003.50078","volume":"41","author":"WF Keane","year":"2003","unstructured":"Keane WF and Lyle PA (2003) Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. Am J Kidney Dis 41 (Suppl 1): S22\u2013S25","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR52","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/j.1523-1755.2004.00925.x","volume":"66","author":"K Rossing","year":"2004","unstructured":"Rossing K et al. (2004) Progression of nephropathy in type 2 diabetic patients. Kidney Int 66: 1596\u20131605","journal-title":"Kidney Int"},{"key":"BFncpneph0378_CR53","first-page":"2","volume":"17","author":"HM Lafferty","year":"1991","unstructured":"Lafferty HM et al. (1991) Anemia: a potent modulator of renal hemodynamics in models of progressive renal disease. Am J Kidney Dis 17: 2\u20137","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR54","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/ndt\/16.2.307","volume":"16","author":"P Jungers","year":"2001","unstructured":"Jungers P et al. (2001) Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 16: 307\u2013312","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0378_CR55","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000190270","volume":"77","author":"S Kuriyama","year":"1997","unstructured":"Kuriyama S et al. (1997) Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77: 176\u2013185","journal-title":"Nephron"},{"key":"BFncpneph0378_CR56","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Drueke","year":"2006","unstructured":"Drueke TB et al. (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071\u20132084","journal-title":"N Engl J Med"},{"key":"BFncpneph0378_CR57","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK et al. (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085\u20132098","journal-title":"N Engl J Med"},{"key":"BFncpneph0378_CR58","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00125-006-0215-6","volume":"49","author":"MC Thomas","year":"2006","unstructured":"Thomas MC et al. (2006) Anaemia in diabetes: is there a rationale to TREAT? Diabetologia 49: 1151\u20131157","journal-title":"Diabetologia"},{"key":"BFncpneph0378_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0735-1097(02)01938-1","volume":"40","author":"MJ Sarnak","year":"2002","unstructured":"Sarnak MJ et al. (2002) Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 40: 27\u201333","journal-title":"J Am Coll Cardiol"},{"key":"BFncpneph0378_CR60","first-page":"16","volume":"6","author":"A Zeidman","year":"2004","unstructured":"Zeidman A et al. (2004) Anaemia as a risk factor for ischemic heart disease. Isr Med Assoc J 6: 16\u201318","journal-title":"Isr Med Assoc J"},{"key":"BFncpneph0378_CR61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","volume":"107","author":"JA Ezekowitz","year":"2003","unstructured":"Ezekowitz JA et al. (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 107: 223\u2013225","journal-title":"Circulation"},{"key":"BFncpneph0378_CR62","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJM199808273390903","volume":"339","author":"A Besarab","year":"1998","unstructured":"Besarab A et al. (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584\u2013590","journal-title":"N Engl J Med"},{"key":"BFncpneph0378_CR63","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cardfail.2004.06.435","volume":"11","author":"PE Sandgren","year":"2005","unstructured":"Sandgren PE et al. (2005) Anemia and new-onset congestive heart failure in the general Medicare population. J Card Fail 11: 99\u2013105","journal-title":"J Card Fail"},{"key":"BFncpneph0378_CR64","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.amjcard.2003.12.062","volume":"93","author":"S Brucks","year":"2004","unstructured":"Brucks S et al. (2004) Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 93: 1055\u20131057","journal-title":"Am J Cardiol"},{"key":"BFncpneph0378_CR65","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","volume":"101","author":"RB Devereux","year":"2000","unstructured":"Devereux RB et al. (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101: 2271\u20132276","journal-title":"Circulation"},{"key":"BFncpneph0378_CR66","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S0272-6386(00)70334-9","volume":"35","author":"T Hayashi","year":"2000","unstructured":"Hayashi T et al. (2000) Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35: 250\u2013256","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR67","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ndt\/18.1.141","volume":"18","author":"DS Silverberg","year":"2003","unstructured":"Silverberg DS et al. (2003) The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 18: 141\u2013146","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0378_CR68","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1046\/j.1523-1755.2002.00142.x","volume":"61","author":"Y Kuwabara","year":"2002","unstructured":"Kuwabara Y et al. (2002) Cerebral blood flow and vasodilatory capacity in anemia secondary to chronic renal failure. Kidney Int 61: 564\u2013569","journal-title":"Kidney Int"},{"key":"BFncpneph0378_CR69","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/ndt\/12.6.1155","volume":"12","author":"MR Langenfeld","year":"1997","unstructured":"Langenfeld MR et al. (1997) Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension? Nephrol Dial Transplant 12: 1155\u20131160","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph0378_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0002-9343(92)90012-Z","volume":"92","author":"ND Vaziri","year":"1992","unstructured":"Vaziri ND et al. (1992) Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome. Am J Med 92: 35\u201340","journal-title":"Am J Med"},{"key":"BFncpneph0378_CR71","first-page":"407","volume":"57","author":"M Kobusiak-Prokopowicz","year":"2002","unstructured":"Kobusiak-Prokopowicz M and Jodla-Mydlowska B (2002) Erythropoietin in patients with essential hypertension. Kardiol Pol 57: 407\u2013414","journal-title":"Kardiol Pol"},{"key":"BFncpneph0378_CR72","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0895-7061(99)00081-3","volume":"12","author":"Y Wada","year":"1999","unstructured":"Wada Y et al. (1999) Erythropoietin impairs endothelium-dependent vasorelaxation through cyclooxygenase-dependent mechanisms in humans. Am J Hypertens 12: 980\u2013987","journal-title":"Am J Hypertens"},{"key":"BFncpneph0378_CR73","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1525-139X.2006.00173.x","volume":"19","author":"X Zhu","year":"2006","unstructured":"Zhu X and Perazella MA (2006) Nonhematologic complications of erythropoietin therapy. Semin Dial 19: 279\u2013284","journal-title":"Semin Dial"},{"key":"BFncpneph0378_CR74","first-page":"233","volume":"39","author":"MD Davis","year":"1998","unstructured":"Davis MD et al. (1998) Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 39: 233\u2013252","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFncpneph0378_CR75","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0895-4356(96)00335-6","volume":"50","author":"Q Qiao","year":"1997","unstructured":"Qiao Q et al. (1997) The relationship between hemoglobin levels and diabetic retinopathy. J Clin Epidemiol 50: 153\u2013158","journal-title":"J Clin Epidemiol"},{"key":"BFncpneph0378_CR76","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/0272-6386(95)90175-2","volume":"26","author":"EA Friedman","year":"1995","unstructured":"Friedman EA et al. (1995) Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 26: 202\u2013208","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR77","doi-asserted-by":"crossref","unstructured":"Friedman EA et al. (2003) Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. Kidney Int 64 (Suppl 87): S57\u2013S63","DOI":"10.1046\/j.1523-1755.64.s87.9.x"},{"key":"BFncpneph0378_CR78","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/BF00418351","volume":"39","author":"A Veves","year":"1996","unstructured":"Veves A et al. (1996) The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients. Diabetologia 39: 344\u2013348","journal-title":"Diabetologia"},{"key":"BFncpneph0378_CR79","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1073\/pnas.0307823100","volume":"101","author":"R Bianchi","year":"2004","unstructured":"Bianchi R et al. (2004) Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci USA 101: 823\u2013828","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneph0378_CR80","first-page":"121","volume":"16","author":"K Hassan","year":"2003","unstructured":"Hassan K et al. (2003) Effect of erythropoietin therapy on polyneuropathy in predialytic patients. J Nephrol 16: 121\u2013125","journal-title":"J Nephrol"},{"key":"BFncpneph0378_CR81","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.2337\/diacare.26.8.2378","volume":"26","author":"L Kessler","year":"2003","unstructured":"Kessler L et al. (2003) Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 26: 2378\u20132382","journal-title":"Diabetes Care"},{"key":"BFncpneph0378_CR82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1024\/0301-1526.29.2.112","volume":"29","author":"C Schmidt-Lucke","year":"2000","unstructured":"Schmidt-Lucke C et al. (2000) Incidence of cutaneous vasoactivity in patients with anaemia and pulmonary hypoxia. Vasa 29: 112\u2013115","journal-title":"Vasa"},{"key":"BFncpneph0378_CR83","first-page":"1005","volume":"73","author":"AO Akanji","year":"1989","unstructured":"Akanji AO et al. (1989) Factors influencing the outcome of treatment of foot lesions in Nigerian patients with diabetes mellitus. Q J Med 73: 1005\u20131014","journal-title":"Q J Med"},{"key":"BFncpneph0378_CR84","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0002-9343(97)00163-0","volume":"103","author":"LA Lavery","year":"1997","unstructured":"Lavery LA et al. (1997) Institutionalization following diabetes-related lower extremity amputation. Am J Med 103: 383\u2013388","journal-title":"Am J Med"},{"key":"BFncpneph0378_CR85","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/01.CCM.0000208151.95920.CB","volume":"34","author":"N Vlahakis","year":"2006","unstructured":"Vlahakis N (2006) Is erythropoietin the key to optimize wound healing? Crit Care Med 34: 1279\u20131280","journal-title":"Crit Care Med"},{"key":"BFncpneph0378_CR86","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1053\/ajkd.1998.v32.pm9740167","volume":"32","author":"M Wakeen","year":"1998","unstructured":"Wakeen M and Zimmerman S (1998) Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis. Am J Kidney Dis 32: 488\u2013493","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0378_CR87","volume-title":"The Cochrane Database of Systematic Reviews","author":"J Cody","year":"2001","unstructured":"Cody J et al. (2001) Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. The Cochrane Database of Systematic Reviews, Issue 4, Art. No CD003266.pub2"},{"issue":"Suppl 2","key":"BFncpneph0378_CR88","first-page":"Sii1","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F et al. (2004) Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 19 (Suppl 2): Sii1\u2013Sii4755","journal-title":"Nephrol Dial Transplant"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0378","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:16:16Z","timestamp":1684440976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["BFncpneph0378"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0378","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}